Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registryMaher Hanoun, Christine Hanoun, Kerstin Schäfer‐Eckart et al.|Journal of Cancer Research and Clinical Oncology|2022Cited by 9
Intensified Cytarabine Dose during Consolidation Therapy in AML Patients Under 65 Years Is Not Associated with Survival BenefitMaher Hanoun, Christoph Röllig, Leo Ruhnke et al.|Blood|2021Cited by 0